Day: June 23, 2025

LEADING EDGE MATERIALS’ INVESTOR UPDATE ON SIGNIFICANT ACTIVITIES Vancouver, June 22, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) provides an investor update on significant activities. Overview – Becoming a European CRM producer Concerns about critical raw materials – security of supply, supply chain resilience and defence requirements – have been recurring themes at conferences attended by the Company in recent months, with Heavy Rare Earth Elements (“HREEs”) and natural graphite frequently mentioned; geopolitical uncertainty is the new norm and it is driving partnership, collaboration and greater levels of support for mining. On June 17, 2025, the G7 Critical Minerals Action Plan was announced focused on ‘diversifying the responsible...

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 23 June 2025 at 9.30 EEST         141,959 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 141,959 A shares have been converted into 141,959 B shares. The conversion has been entered into the Trade Register on 23 June 2025. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,308,783 A shares and 108,825,495 B shares. The number of votes of the company’s shares is after the conversion 755,001,155. Orion CorporationLiisa Hurme President and CEO     Mikko Kemppainen General Counsel  Contact person:Tuukka Hirvonen, Head of Investor Relations, tel. +358 10 426 2721                        ...

Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO AMSTERDAM, June 23, 2025 – Antonio Filosa today takes up the role as Chief Executive Officer of Stellantis N.V. and announces his new Stellantis Leadership Team, effective immediately, drawing on the deep bench of industry expertise from Stellantis’ teams around the world. “It is my great privilege to take the lead of Stellantis, a global company with deep regional roots,” said CEO Antonio Filosa. “We have unique strengths in our great people, our iconic brands and our millions of customers, whose loyalty to our Company, its fantastic products and its unique stories can only inspire us to new achievements.” The new appointments, which build on the organizational changes announced in February 2025, underline Stellantis’ breadth and depth of talent. The team structure...

Better than expected grades and widths from drilling in multiple areas anticipated to boost gold resources at Blanket ST HELIER, Jersey, June 23, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) is pleased to report further encouraging high grade results from the ongoing resource expansion drill programme at Caledonia’s 64% owned Blanket Mine. The programme is aimed at evaluating the continuity of the mineralised zones on the Blanket, Eroica and Lima orebodies (which comprise three of the main orebodies at Blanket Mine). The objectives of the programme are to increase the confidence levels of the existing mineral resource and to grow the mineral resource estimate below the 34 level of the mine (1,110 metres).  These results follow the previously announced results on January...

Company announcement no. 35 / 2025Schindellegi, Switzerland – 23 June 2025 Trifork Group: Weekly report on share buybackOn 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no. 7 of 28 February 2025. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 14.92 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 256,329 treasury shares, corresponding to 1.3% of the share capital. Under the program, the following transactions have been...

Positive phase I/II data presented at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress show NXT007 achieved no bleeds requiring treatment in the highest dose groups in people with haemophilia A1 The NXT007 clinical development programme aims to normalise haemostasis and minimise treatment burden2,3 Three phase III clinical studies on NXT007, a next-generation bispecific antibody, set to begin in 20261Basel, 23 June 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive phase I/II data on NXT007 in people with haemophilia A, supporting its progression into phase III clinical development. NXT007 is a next-generation investigational bispecific antibody, engineered by Chugai, a member of the Roche Group. Early data from the NXTAGE study suggest that NXT007 may have the potential to provide...

Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myelomaRecommendation based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit and prolonged PFS compared to VRd alone If approved, it would represent the fourth indication in the EU and second in the front-line setting globallyParis, June 23, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the induction treatment of adult patients with newly diagnosed multiple myeloma (NDMM) who are eligible for autologous stem cell transplant. A final decision is expected in the coming...

23 June 2025, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR We have been notified that, Aurora Value Fund, a fund organized and existing under the laws of Liechtenstein, registered with the Liechtenstein Investment Fund Association (LAFV) under register number FL-0002.305.581-2 represented and acting through its management company CAIAC Fund Management AG, a company incorporated under the laws of Liechtenstein, with registered office at Haus Atzig, Industriestrasse 2, 9487 Bendern, Liechtenstein as part of a fund liquidation contributed in kind 59.94% of the voting rights in EPH European Property Holdings PLC  by contributing 8,636,897 shares to several investors. The transaction was executed on 16th June 2025, and the notification was duly submitted to the Disclosure Office of SIX Exchange Regulation. The Company has been...

Ad hoc announcement pursuant to Art. 53 LRIdorsia to receive USD 50 million (an additional USD 30 million) approval milestone payment in return for a reduction in Simcere potential sales milestones and tiered royalty payments.Allschwil, Switzerland – June 23, 2025Idorsia Ltd. (SIX: IDIA) today announced that Simcere Pharmaceuticals Group Ltd (2096.HK, “Simcere”) has received approval for QUVIVIQ® (daridorexant) from the Chinese National Medical Products Administration for the treatment of adult patients with insomnia characterized by difficulty falling asleep and/or maintaining sleep, with no psychotropic drug control labeling. In addition, Idorsia has reached an agreement with Simcere to update the terms of the licensing agreement for QUVIVIQ in China. André C. Muller, Chief Executive Officer of Idorsia, commented:“I want to congratulate...